HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,541,000 | +13.6% | 1,161,057 | +1.3% | 0.00% | – |
Q3 2016 | $3,116,000 | -1.6% | 1,145,689 | +3.5% | 0.00% | -100.0% |
Q2 2016 | $3,167,000 | -26.1% | 1,107,355 | -22.0% | 0.00% | 0.0% |
Q1 2016 | $4,285,000 | -13.7% | 1,418,948 | -0.8% | 0.00% | 0.0% |
Q4 2015 | $4,965,000 | +0.1% | 1,430,778 | +9.0% | 0.00% | 0.0% |
Q3 2015 | $4,962,000 | -39.7% | 1,312,648 | -9.1% | 0.00% | 0.0% |
Q2 2015 | $8,234,000 | +5.8% | 1,444,524 | +8.1% | 0.00% | 0.0% |
Q1 2015 | $7,779,000 | -0.5% | 1,336,590 | -3.0% | 0.00% | 0.0% |
Q4 2014 | $7,815,000 | +47.7% | 1,378,389 | +6.5% | 0.00% | 0.0% |
Q3 2014 | $5,292,000 | -5.2% | 1,293,843 | +5.5% | 0.00% | 0.0% |
Q2 2014 | $5,581,000 | -32.3% | 1,226,565 | -29.5% | 0.00% | 0.0% |
Q1 2014 | $8,249,000 | +10.1% | 1,740,311 | +9.2% | 0.00% | 0.0% |
Q4 2013 | $7,491,000 | -18.0% | 1,593,827 | -8.2% | 0.00% | -50.0% |
Q3 2013 | $9,131,000 | -11.8% | 1,735,848 | -21.2% | 0.00% | 0.0% |
Q2 2013 | $10,354,000 | – | 2,202,998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |